Evidence map›Paper›PMID 31048670›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2019

Sperm Cryopreservation for Male Cancer Patients: More than 10 Years of Experience, in Beijing China.

Longlong Fu, Fang Zhou, Qi An, Kaishu Zhang, Xiaowei Wang, Jianfeng Xu, Ying Guo, Wenhong Lu, Xiaowei Liang, Yiqun Gu

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. ABVD and BEACOPP regimens' effects on fertility in young males with Hodgkin lymphoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Enhancement of Frozen-Thawed Human Sperm Quality with Zinc as a Cryoprotective Additive.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Spermatogonial Stem Cell Culture in Oncofertility.The Urologic clinics of North America · 2020
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Longlong FuDepartment of Male Clinical Research/Human Sperm Bank, National Research Institute for Family Planning, and WHO Collaborating Centre for Research in Human Reproduction, Beijing, China (mainland).
Fang ZhouDepartment of Male Clinical Research/Human Sperm Bank, National Research Institute for Family Planning, and WHO Collaborating Centre for Research in Human Reproduction, Beijing, China (mainland).
Qi AnDepartment of Male Clinical Research/Human Sperm Bank, National Research Institute for Family Planning, and WHO Collaborating Centre for Research in Human Reproduction, Beijing, China (mainland).
Kaishu ZhangDepartment of Reproductive Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Xiaowei WangDepartment of Male Clinical Research/Human Sperm Bank, National Research Institute for Family Planning, and WHO Collaborating Centre for Research in Human Reproduction, Beijing, China (mainland).
Jianfeng XuDepartment of Male Clinical Research/Human Sperm Bank, National Research Institute for Family Planning, and WHO Collaborating Centre for Research in Human Reproduction, Beijing, China (mainland).
Ying GuoDepartment of Male Clinical Research/Human Sperm Bank, National Research Institute for Family Planning, and WHO Collaborating Centre for Research in Human Reproduction, Beijing, China (mainland).
Wenhong LuDepartment of Male Clinical Research/Human Sperm Bank, National Research Institute for Family Planning, and WHO Collaborating Centre for Research in Human Reproduction, Beijing, China (mainland).
Xiaowei LiangDepartment of Male Clinical Research/Human Sperm Bank, National Research Institute for Family Planning, and WHO Collaborating Centre for Research in Human Reproduction, Beijing, China (mainland).
Yiqun GuDepartment of Male Clinical Research/Human Sperm Bank, National Research Institute for Family Planning, and WHO Collaborating Centre for Research in Human Reproduction, Beijing, China (mainland).
National Health and Family Planning Commission · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Fertility preservation is very important for male cancer patients, especially adolescents. Unfortunately, the use of fertility preservation is very low among Chinese male cancer patients. Additionally, the cumulative rate of frozen sperm use is also low. MATERIAL AND METHODS We performed a retrospective study by collecting available information at the Human Sperm Bank, National Research Institute for Family Planning from July 2006 to December 2017 to examine the data in China. RESULTS A total 145 male cancer patients underwent sperm cryopreservation. The patients were 29.3±6.9 years old, and 6.2% (9 out of 145) of the patients were adolescents under the age of 18 years old. As of June 2018, only 9.7% (14 out of 145) of patients returned to use their cryopreserved sperm for assisted reproduction technology (ART). Of the 33 ART cycles, conceptions were achieved in 51.5% (17 out of 33), and the rate of patients who had a baby was 71.4% (10 out of 14). The data indicate men with testicular cancer or leukemia had lower total sperm counts and recovery rate of progressive sperm than did men with other types of cancer, while men with sarcoma had the lowest progressive sperm. CONCLUSIONS The physician should make an effort to promote fertility preservation for male cancer patients in China. And patients with testicular cancer and leukemia require additional attention.

Indexed as

SpermatozoaAdolescentAdultBeijingCryopreservationFertility PreservationHumansInfertility, MaleMaleNeoplasmsReproductive Techniques, AssistedRetrospective StudiesYoung Adult

Identifiers

PMID31048670
PMCPMC6511111
OpenAlexW2942515469

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.